C4 Therapeutics, Inc.
CCCCNasdaqCIK 1662579HealthcareFiscal year ends Dec 31
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006142 |
| 2024-01-1107:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-001085 |
| 2024-01-0916:06 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000947 |
| 2023-12-1216:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-041317 |
| 2023-12-1207:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-041271 |
| 2023-11-2007:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-039562 |
| 2023-11-0107:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-035793 |
| 2023-11-0107:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-035790 |
| 2023-09-0516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-031375 |
| 2023-08-0807:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027941 |
| 2023-08-0807:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027935 |
| 2023-06-2007:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-23-022597 |
| 2023-05-3007:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-23-020025 |
| 2023-05-0407:46 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-015459 |
| 2023-05-0407:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-015454 |
| 2023-04-2807:01 ET | DEF 14A | Proxy statement | 0001628280-23-013738 |
| 2023-02-2316:18 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-004835 |
| 2023-02-2308:53 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-004711 |
| 2023-02-2307:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001662579-23-000040 |
| 2023-02-0216:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628280-23-002041 |
| 2023-01-0907:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-000725 |
| 2022-11-0307:50 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-027985 |
| 2022-11-0307:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-027966 |
| 2022-09-2207:41 ET | 8-K/A | 5.07 Shareholder vote results | 0001628280-22-025322 |
| 2022-08-0408:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-020886 |
| 2022-08-0408:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-020884 |
| 2022-08-0208:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-020108 |
| 2022-06-2416:00 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-024179 |
| 2022-06-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-22-023555 |
| 2022-05-1616:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-22-020438 |
| 2022-05-0508:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-018046 |
| 2022-05-0508:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-018044 |
| 2022-04-2909:15 ET | DEF 14A | Proxy statementPeriod 2022-06-22 | 0001193125-22-130938 |
| 2022-04-0813:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-22-013950 |
| 2022-03-1616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-010644 |
| 2022-02-2407:42 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-006499 |
| 2022-02-2407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-006496 |
| 2022-01-2116:12 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-22-014812 |
| 2022-01-1007:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-22-000773 |
| 2021-11-3016:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001564590-21-058797 |
| 2021-11-1016:27 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056223 |
| 2021-11-1016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-056196 |
| 2021-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043442 |
| 2021-08-1116:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-043428 |
| 2021-06-2116:26 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-033633 |
| 2021-06-1508:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-190646 |
| 2021-06-1416:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-032781 |
| 2021-06-1416:06 ET | S-1 | Registration statement | 0001193125-21-190020 |
| 2021-06-0707:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-031858 |
| 2021-05-2616:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-030041 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 12:02 ET. Listed shows no prices and gives no investment advice.